Lv H - Search Results

1

Intense basolateral membrane staining indicates HER2 positivity in invasive micropapillary breast carcinoma.

Zhou S, Yang F, Bai Q, Li A, Li M, Zhong S, Lv H, Shui R, Tu X, Bi R, Xu X, Cheng Y, Yu B, Tang S, Sun X, Zhou X, Yang W. Zhou S, et al. Among authors: lv h. Mod Pathol. 2020 Jul;33(7):1275-1286. doi: 10.1038/s41379-020-0461-z. Epub 2020 Jan 23. Mod Pathol. 2020. PMID: 31974492 Free article.

2

SPAG5 upregulation contributes to enhanced c-MYC transcriptional activity via interaction with c-MYC binding protein in triple-negative breast cancer.

Li M, Li A, Zhou S, Lv H, Yang W. Li M, et al. Among authors: lv h. J Hematol Oncol. 2019 Feb 8;12(1):14. doi: 10.1186/s13045-019-0700-2. J Hematol Oncol. 2019. PMID: 30736840 Free PMC article.

3

Impact of the Updated 2018 American Society of Clinical Oncology/College of American Pathologists Guideline for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer.

Li A, Bai Q, Kong H, Zhou S, Lv H, Zhong S, Li M, Bi R, Zhou X, Yang W. Li A, et al. Among authors: lv h. Arch Pathol Lab Med. 2020 Sep 1;144(9):1097-1107. doi: 10.5858/arpa.2019-0369-OA. Arch Pathol Lab Med. 2020. PMID: 32142367 Free article.

4

Molecular Subtyping of Triple-Negative Breast Cancers by Immunohistochemistry: Molecular Basis and Clinical Relevance.

Zhao S, Ma D, Xiao Y, Li XM, Ma JL, Zhang H, Xu XL, Lv H, Jiang WH, Yang WT, Jiang YZ, Zhang QY, Shao ZM. Zhao S, et al. Among authors: lv h. Oncologist. 2020 Oct;25(10):e1481-e1491. doi: 10.1634/theoncologist.2019-0982. Epub 2020 Jun 1. Oncologist. 2020. PMID: 32406563 Free PMC article.

5

RNA-binding protein MSI2 isoforms expression and regulation in progression of triple-negative breast cancer.

Li M, Li AQ, Zhou SL, Lv H, Wei P, Yang WT. Li M, et al. Among authors: lv h. J Exp Clin Cancer Res. 2020 May 24;39(1):92. doi: 10.1186/s13046-020-01587-x. J Exp Clin Cancer Res. 2020. PMID: 32448269 Free PMC article.

6

High frequency of PIK3CA and TERT promoter mutations in fibromatosis-like spindle cell carcinomas.

Zhong S, Zhou S, Li A, Lv H, Li M, Tang S, Xu X, Shui R, Yang W. Zhong S, et al. Among authors: lv h. J Clin Pathol. 2022 Jul;75(7):477-482. doi: 10.1136/jclinpath-2020-207071. Epub 2021 May 5. J Clin Pathol. 2022. PMID: 33952589

7

Epithelioid leiomyosarcoma of broad ligament harboring PGR-NR4A3 and UBR5-PGR gene fusions: a unique case report.

Ren H, Li Y, Yao Q, Lv H, Tang S, Zhou X, Yang W. Ren H, et al. Among authors: lv h. Virchows Arch. 2022 Apr;480(4):933-938. doi: 10.1007/s00428-021-03169-4. Epub 2021 Aug 5. Virchows Arch. 2022. PMID: 34351486

8

FOXC1.

Li M, Lv H, Zhong S, Zhou S, Lu H, Yang W. Li M, et al. Among authors: lv h. Arch Pathol Lab Med. 2022 Aug 1;146(8):994-1003. doi: 10.5858/arpa.2021-0039-OA. Arch Pathol Lab Med. 2022. PMID: 34784418 Free article.

9

A clinicopathological study and survival analysis of 99 breast cancers with HER2/CEP17 ratio ≥ 2.0 and an average HER2 copy number < 4.0 per cell in China.

Zhou S, Lv H, Li A, Li M, Zhong S, Lu H, Zhou X, Bai Q, Yang W. Zhou S, et al. Among authors: lv h. BMC Cancer. 2023 Jan 25;23(1):84. doi: 10.1186/s12885-023-10531-z. BMC Cancer. 2023. PMID: 36698078 Free PMC article.

10

FOXC1 and SOX10 in Estrogen Receptor-Low Positive/HER2-Negative Breast Cancer: Potential Biomarkers for the Basal-like Phenotype Prediction.

Li M, Zhou S, Lv H, Cai M, Wan X, Lu H, Shui R, Yang W. Li M, et al. Among authors: lv h. Arch Pathol Lab Med. 2024 Apr 1;148(4):461-470. doi: 10.5858/arpa.2022-0370-OA. Arch Pathol Lab Med. 2024. PMID: 37406289 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,922 results

Search Page

Filters